Navigation Links
Allen Technologies, Inc. Announces Vigo Interactive Communication and Education System Agreement with Saint John's Health Center, Santa Monica, California
Date:1/12/2009

a national reputation as an exceptional place for health and healing," said Gary Cowsert, President and CEO of Allen Technologies. "We are honored to have been selected by Saint John's as its Interactive Patient Care System of choice. Our Vigo system is a perfect fit for Saint John's mission of bringing the most advanced patient care available in a compassionate, healing environment."

About Saint John's Health Center
Since its founding in 1942 by the Sisters of Charity of Leavenworth, Saint John's Health Center has been providing the patients and families of Santa Monica, West Los Angeles and ocean communities with compassionate, advanced medical care. Saint John's provides a spectrum of treatment and diagnostic services with distinguished areas of excellence in cancer care, cardiac care, orthopedics, women's health and specialized programs such as the internationally acclaimed John Wayne Cancer Institute. Saint John's Health Center is dedicated to bringing to the community the most innovative advances in medicine and technology.

About Allen Technologies, Inc.
Allen Technologies' Vigo Interactive Patient Communication System transforms hospital TVs into an interactive communication and education system that improves quality of care, patient satisfaction, and patient safety performance. Founded in 1977, Allen Technologies has been pioneering interactive network solutions exclusively for hospitals since 1982. Today, Allen Technologies systems touch over 50,000 patients daily. You may learn more about Allen Technologies at www.allentek.com.

# # #

Read the full story at http://www.prweb.com/releases/2009/01/prweb1837144.htm


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Studies Challenge Framingham Risk Score
2. Study to explore ethical challenges health professionals face while caring for children with LTNMDs
3. Kyp Systems Takes on the Challenge of New Pharmaceutical Marketing Guidelines
4. Challenges in Diagnosing Psychotic and Mood Disorders
5. Diabetes Epidemic Now Poses Challenges for Nursing Homes
6. SCAN Health Plan Arizona Helps Drivers Understand the Challenges of Aging
7. Crest and Oral-B Challenge America to See The Difference in Their Smile and Make A Difference in Childrens Smiles Around the World
8. General Mills, NBCs The Biggest Loser and Feeding America Partner to Launch Pound For Pound Challenge
9. MaxCyte Presents a Panel Discussion With Industry Experts on the Challenges in Developing Cell-Based Screening Assays for Drug Discovery - LIVE Q&A to Follow
10. Discovery Healths NATIONAL BODY CHALLENGE Weighs in for a Sixth Season, Urging Americans to Break up With Bad Habits
11. Make a Mental Wellness New Years Resolution: How to Reduce Stress and Maintain Mental Health and Wellness in the Face of Economic Challenges
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Nearly 100 HIV/AIDS Drugs and Vaccines in Development Pipeline 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8PROSTVAC 28TM 29 Data Presented at the ASCO Meeting Demonstrates the Potential for Significant Increases in Life Expectancy in Late Stage Prostate Can 12379 1PROSTVAC 28TM 29 Data Presented at the ASCO Meeting Demonstrates the Potential for Significant Increases in Life Expectancy in Late Stage Prostate Can 12379 2PROSTVAC 28TM 29 Data Presented at the ASCO Meeting Demonstrates the Potential for Significant Increases in Life Expectancy in Late Stage Prostate Can 12379 3Valeant Pharmaceuticals Reports Encouraging Final Results With Taribavirin Phase IIb Study 12376 1Valeant Pharmaceuticals Reports Encouraging Final Results With Taribavirin Phase IIb Study 12376 2Valeant Pharmaceuticals Reports Encouraging Final Results With Taribavirin Phase IIb Study 12376 3Valeant Pharmaceuticals Reports Encouraging Final Results With Taribavirin Phase IIb Study 12376 4Back to normal 3A Surgery improves outcomes for spine patients 47438 1Back to normal 3A Surgery improves outcomes for spine patients 47438 2